Mirtazapine and Citalopram Combination Therapy

Introduction to Combination Therapy

The American Academy of Child and Adolescent Psychiatry recommends that mirtazapine and citalopram can be given together with appropriate caution and monitoring for serotonin syndrome, though the combination requires careful dose titration and vigilant surveillance, particularly in the first 24-48 hours after initiation or dose changes 1, 2, 3

The American Academy of Child and Adolescent Psychiatry notes that the primary concern when combining these medications is serotonin syndrome, which occurs when serotonergic medications are combined and can develop within 24-48 hours 1, 2, 3
The FDA warns that concomitant use of mirtazapine with SSRIs, including citalopram, increases the risk of serotonin syndrome and requires monitoring for signs and symptoms, particularly during treatment initiation and dosage increases 1, 2, 3
Symptoms of serotonin syndrome include mental status changes, such as confusion, agitation, and anxiety, as well as neuromuscular hyperactivity, autonomic hyperactivity, and advanced symptoms like fever and seizures 1, 2, 3
Citalopram may cause QT prolongation associated with Torsades de Pointes, ventricular tachycardia, and sudden death at daily doses exceeding 40 mg/day, and should be avoided in patients with long QT syndrome 1, 2, 4, 5

The American Heart Association notes that mirtazapine has been shown to be safe in cardiovascular disease patients, though its efficacy in treating depression in this population hasn't been fully assessed 6, 7
SSRIs like citalopram are well-studied in coronary heart disease and heart failure and appear safe, though sertraline may have a lower risk of QTc prolongation than citalopram 6, 7

The American Academy of Child and Adolescent Psychiatry recommends starting the second serotonergic drug at a low dose, beginning with mirtazapine at 15 mg daily, and keeping citalopram at or below 40 mg daily, with further reductions for patients older than 60 years 1, 2, 4, 5
The American Academy of Child and Adolescent Psychiatry also recommends titrating doses gradually with close monitoring, watching for serotonin syndrome symptoms, and assessing cardiac risk with baseline ECG if the patient has cardiac risk factors 1, 2, 3, 4, 5

The American Academy of Child and Adolescent Psychiatry warns that the combination of mirtazapine and citalopram is absolutely contraindicated with MAOIs due to severe serotonin syndrome risk 1, 2, 3